Formosa Laboratories, Inc. (TPE:4746)
Taiwan
· Delayed Price · Currency is TWD 55.00
-0.60 (-1.08%)
Apr 29, 2026, 1:30 PM CST
Formosa Laboratories Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 4,851 | 4,731 | 4,360 | 3,766 | 3,142 | Upgrade
|
| Revenue Growth (YoY) | 2.54% | 8.50% | 15.80% | 19.83% | 2.18% | Upgrade
|
| Cost of Revenue | 2,819 | 2,682 | 2,437 | 2,375 | 2,171 | Upgrade
|
| Gross Profit | 2,032 | 2,049 | 1,923 | 1,390 | 971.44 | Upgrade
|
| Selling, General & Admin | 510.08 | 502.26 | 432.95 | 421.34 | 453.14 | Upgrade
|
| Research & Development | 727.91 | 796.42 | 841.87 | 777.02 | 700.2 | Upgrade
|
| Operating Expenses | 1,229 | 1,323 | 1,248 | 1,227 | 1,139 | Upgrade
|
| Operating Income | 803.18 | 725.9 | 674.98 | 163.49 | -168.02 | Upgrade
|
| Interest Expense | -33.12 | -39.61 | -34.74 | -19.32 | -28.05 | Upgrade
|
| Interest & Investment Income | 32.26 | 32.24 | 23.71 | 2.14 | 0.36 | Upgrade
|
| Earnings From Equity Investments | 8.71 | -2.16 | 5.56 | 7.59 | 9.17 | Upgrade
|
| Currency Exchange Gain (Loss) | -163.09 | 25.98 | -65.78 | 10.38 | -6.86 | Upgrade
|
| Other Non Operating Income (Expenses) | 35.55 | 7.38 | 2 | 168.82 | 1,318 | Upgrade
|
| EBT Excluding Unusual Items | 683.48 | 749.71 | 605.73 | 333.11 | 1,124 | Upgrade
|
| Gain (Loss) on Sale of Investments | -181.82 | -523.05 | -428.92 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.09 | -21.61 | 0.09 | 0.05 | 0.11 | Upgrade
|
| Other Unusual Items | 0.01 | -6.9 | -34.51 | 0.02 | -36.9 | Upgrade
|
| Pretax Income | 501.75 | 198.15 | 142.39 | 333.18 | 1,088 | Upgrade
|
| Income Tax Expense | 105.72 | 134.08 | 194.65 | 116.37 | 44.01 | Upgrade
|
| Earnings From Continuing Operations | 396.03 | 64.08 | -52.26 | 216.81 | 1,044 | Upgrade
|
| Minority Interest in Earnings | 45.08 | 93.19 | 178.5 | 192.55 | 205.58 | Upgrade
|
| Net Income | 441.11 | 157.27 | 126.24 | 409.36 | 1,249 | Upgrade
|
| Net Income to Common | 441.11 | 157.27 | 126.24 | 409.36 | 1,249 | Upgrade
|
| Net Income Growth | 180.48% | 24.58% | -69.16% | -67.23% | 212.25% | Upgrade
|
| Shares Outstanding (Basic) | 120 | 120 | 120 | 120 | 114 | Upgrade
|
| Shares Outstanding (Diluted) | 121 | 121 | 120 | 121 | 121 | Upgrade
|
| Shares Change (YoY) | 0.24% | 0.41% | -0.33% | -0.51% | 2.79% | Upgrade
|
| EPS (Basic) | 3.67 | 1.31 | 1.05 | 3.40 | 10.92 | Upgrade
|
| EPS (Diluted) | 3.64 | 1.30 | 1.05 | 3.39 | 10.32 | Upgrade
|
| EPS Growth | 180.00% | 23.84% | -69.03% | -67.14% | 198.32% | Upgrade
|
| Free Cash Flow | 518.17 | 140.38 | 288.07 | 204.66 | -197.62 | Upgrade
|
| Free Cash Flow Per Share | 4.27 | 1.16 | 2.39 | 1.69 | -1.63 | Upgrade
|
| Dividend Per Share | 3.000 | 3.000 | 2.000 | 1.000 | 2.000 | Upgrade
|
| Dividend Growth | - | 50.00% | 100.00% | -50.00% | - | Upgrade
|
| Gross Margin | 41.89% | 43.30% | 44.11% | 36.92% | 30.91% | Upgrade
|
| Operating Margin | 16.56% | 15.34% | 15.48% | 4.34% | -5.35% | Upgrade
|
| Profit Margin | 9.09% | 3.32% | 2.90% | 10.87% | 39.75% | Upgrade
|
| Free Cash Flow Margin | 10.68% | 2.97% | 6.61% | 5.44% | -6.29% | Upgrade
|
| EBITDA | 1,344 | 1,225 | 1,155 | 595.07 | 296.59 | Upgrade
|
| EBITDA Margin | 27.70% | 25.90% | 26.49% | 15.80% | 9.44% | Upgrade
|
| D&A For EBITDA | 540.86 | 499.35 | 479.96 | 431.58 | 464.61 | Upgrade
|
| EBIT | 803.18 | 725.9 | 674.98 | 163.49 | -168.02 | Upgrade
|
| EBIT Margin | 16.56% | 15.34% | 15.48% | 4.34% | -5.35% | Upgrade
|
| Effective Tax Rate | 21.07% | 67.66% | 136.70% | 34.93% | 4.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.